213
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Imiquimod-oleic acid prodrug-loaded cream reduced drug crystallinity and induced indistinguishable cytotoxicity and apoptosis in mice melanoma tumour

, , , , &
Pages 759-774 | Received 04 Jun 2019, Accepted 30 Sep 2019, Published online: 06 Nov 2019

References

  • Amini, S., et al., 2010. Non surgical innovations in the treatment of non melanoma skin cancer. J clin aesthet dermatol, 3(6), 20–34.
  • Aspord, C., et al., 2014. Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impding vascularisation. Journal of investigative dermatology, 134(10), 2551–2561.
  • Barry, B.W., 1987. Mode of action of penetration enhancers in human skin. Journal of controlled release, 6(1), 85–97.
  • Barry, B.W. and Meyer, M.C., 1975. Assessment of the spreadability of official pharmaceutical creams and ointments using the master curve concept. Journal of Texture Studies, 6(4), 433–444.
  • Bonde, S., Bonde, C., and Mavani, N., 2018. Formulation, optimization and evaluation of organogel for topical delivery of acyclovir. Current drug delivery, 15(3), 397–405.
  • Bougueon, G., et al., 2016. Formulation and characterization of a 0.1% rapamycin cream for the treatment of tuberous sclerosis complex related angiofibromas. International journal of pharmaceutics, 509, 279–284.
  • Bradshaw, T.D., et al., 1998. 2-(4-Aminophenyl) benzothiazoles: novel agents with selective profiles of in vitro antitumour activity. British journal of cancer, 77(5), 745–752.
  • Bragta, P., et al., 2018. Intratumoural administration of carboplatin bearing poly (ε-caprolactone) nanoparticles amalgamated with in situ gel tendered augmented drug delivery, cytotoxicity, and apoptosis in melanoma tumour. Colloids and surfaces B: biointerfaces, 166, 339–348.
  • Brunngraber, E.G., and Brown, B.D., 1967. Preparation and properties of sialomucopolysaccharides obtained from rat brain. Biochemical journal, 103(1), 65–72.
  • Bubna, A.K., 2015. Imiquimod: Its role in the treatment of cutaneous malignancies. Indian journal of pharmacology, 47(4), 354–359.
  • Chang, R.K., et al., 2013. Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products. The aaps journal, 15(1), 41–52.
  • Chen, M.X., Alexander, K.S., and Baki, G., 2016. Formulation and evaluation of antibacterial creams and gels containing metal ions for topical application. Journal of pharmaceutics, 2016, 10. Article ID 5754349, pages.
  • Chen, Y., Wang, M., and Fang, L., 2013. Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems. Drug delivery, 20(5), 199–209.
  • Chollet J.L., et al. 1998. Zarraga. AAPS Annual Meeting, abstract 2445. San Francisco.
  • Coventry, B.J., Baume, D., and Lilly, C., 2015. Long-term survival in advanced melanoma patients using repeated therapies: successive immunomodulation improving the odds. Cancer management and research, 7, 93–103.
  • El-Khattouti, A., et al., 2016. Imiquimod-induced apoptosis of melanoma cells is mediated by ER stress dependent Noxa induction and enhanced by NF-κB inhibition. Journal of cellular and molecular medicine, 20(2), 266–286.
  • Hanna, E., Abadi, R., and Abbas, O., 2016. Imiquimod in dermatology: an overview. International journal of dermatology, 55(8), 831–844.
  • Harrison, L.I., et al., 2009. A pharmaceutical comparison of different commercially available imiquimod 5% cream products. J dermatolog treat, 10, 1–5.
  • Huang, S.J., et al., 2009. Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin. Journal of investigative dermatology, 129(11), 2676–2685.
  • Jyoti, K., et al., 2017. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells. International journal of biological macromolecules, 98, 50–58.
  • Kaur, A., et al., 2018. Self-assembled nanomicelles of amphiphilic clotrimazole glycyl-glycine analogue augmented drug delivery, apoptosis and restrained melanoma tumour progression. Materials science and engineering: c, 89, 75–86.
  • Kiernan, J. A., 2008. Histological and histochemical methods: theory and practice. 4th ed. Bloxham, UK: Scion.
  • Kim, B.Y., et al., 2005. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation. International journal of pharmaceutics, 293(1-2), 193–202.
  • Lane, M.E., 2013. Skin penetration enhancers. International journal of pharmaceutics, 447(1-2), 12–21.
  • Lopez-Bergami, P., Fitchman, B., and Ronai, Z., 2008. Understanding signaling cascades in melanoma. Photochemistry and photobiology, 84(2), 289–306.
  • Madan, J., et al., 2014. Enhanced noscapine delivery using estrogen receptor targeted nanoparticles for breast cancer therapy. Anti-cancer drugs, 25, 704–716.
  • Marepally, S., et al., 2013. Design, synthesis of novel lipids as chemical permeation enhancers and development of nano particle system for transdermal drug delivery. PLoS one, 8(12), e82581.
  • Marjukka Suhonen, T., Bouwstra, J.A., and Urtti, A., 1999. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. Journal of controlled release, 59(2), 149–161.
  • Marples, M. J., 1965. The ecology of the human skin. Springfield, IL: Charles C Thomas Publisher, 03–154.
  • Matsuzawa, H., et al., 2013. Dynamic molecular behaviour and cluster structure of octanoic acid in its liquid and CCl4 solution. Food and nutrition sciences, 4, 25–32.
  • Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of immunological methods, 65(1–2), 55–63.
  • Naik, A., et al., 1995. Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. Journal of controlled release, 37(3), 299–306.
  • Park, E.K., and Song, K.W., 2010. Rheological evaluation of petroleum jelly as a base material in ointment and cream formulations: steady shear flow behaviour. Archives of pharmacal research, 33(1), 141–150.
  • Pathan, I.B., and Setty, C.M., 2009. Chemical penetration enhancers for transdermal drug delivery systems. Tropical J pharm res, 8, 173–179.
  • Paula, D.D., Martins, C.A., and Bentley, M., 2008. Development and validation of HPLC method for imiquimod determination in skin penetration studies. Biomedical chromatography, 22(12), 1416–1423.
  • Raschke, T., et al., 2004. Topical activity of ascorbic acid: from in vitro optimization to in vivo efficacy. Skin pharmacology and physiology, 17(4), 200–206.
  • Rau, H. and Lessmann, T., 2015. Dipeptide-based prodrug linkers for aliphatic amine-containing drugs. United States Patent US20130053301A1.
  • Redondo, P., et al., 2007. Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions. Journal of investigative dermatology, 127(7), 1673–1680.
  • Rehman, K., Mohd Amin, M.C.I., and Zulfakar, M.H., 2014. Development and physical characterization of polymer-fish oil bigel (hydrogel/oleogel) system as a transdermal drug delivery vehicle. Journal of oleo science, 63(10), 961–970.
  • Rowat, A.C., Kitson, N., and Thewalt, J.L., 2006. Interactions of oleic acid and model stratum corneum membranes as seen by 2H NMR. International journal of pharmaceutics, 307(2), 225–231.
  • Schon, M.P., et al., 2004. Death receptor independent apoptosis in malignant melanoma induced bythe small-molecule immune response modifier imiquimod. Journal of investigative dermatology, 122, 1266–1276.
  • Shah, V.P., Elkins, J.S., and Williams, R.L., 1999. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products. Pharmaceutical development and technology, 4(3), 377–385.
  • Shah, K., et al., 2017. Prodrugs of NSAIDs: A review. The open medicinal chemistry journal, 11(1), 146–195.
  • Shojaei, H., et al., 2009. Toll-like receptors 3 and 7 agonists enhance tumour cell lysis by human gamma delta T cells. Cancer research, 69(22), 8710–8717.
  • Siewert, M., et al., 2003. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS pharmscitech, 4(1), 43.
  • Singh, L., et al., 2015. Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma. Clinical & experimental ophthalmology, 43(3), 259–267.
  • Singh, T.P., et al., 2016. Monocyte derived inflammatory langerhans cells and dermal dendritic cells mediate psoriasis like inflammation. Nature communications, 7(1), 13581.
  • Sioud, M., 2006. Single-stranded small interfering RNAs are more immunostimulatory than their double-stranded counterparts: a central role for 2'-hydroxyl uridines in immune responses. European journal of immunology, 36(5), 1222–1230.
  • Smith, P.K., et al., 1985. Measurement of protein using bicinchoninic acid. Analytical biochemistry, 150(1), 76–85.
  • Soni, N., et al., 2017. Noscapinoids bearing silver nanocrystals augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in B16F1, mouse melanoma skin cancer cells. Biomedicine & pharmacotherapy, 90, 906–913.
  • Statham, A.S. and Nelson, R.J. 2011a. Pharmaceutical cream with reduced imiquimod impurities at four months using refined oleic acid. United States Patent US 7,902,213 B2.
  • Statham, A.S. and Nelson, R.J. 2011b. Method of stabilizing imiquimod. United States Patent 7902242 B2.
  • Statham, A.S. and Nelson, R.J. 2011c. Reduction of imiquimod impurities using refined oleic acid. United States Patent US20100130530 A1.
  • Takeuchi, Y., et al., 1998. Skin penetration enhancing action of cis-unsaturated fatty acids with -9, and -12 chain lengths. Biological & pharmaceutical bulletin, 21(5), 484–491.
  • Varma, S.R., et al., 2017. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. European journal of pharmacology, 813, 33–41.
  • Yan, Y.D., et al., 2011. Evaluation of physicochemical properties, skin permeation and accumulation profiles of salicylic acid amide prodrugs as sunscreen agent. International journal of pharmaceutics, 419(1–2), 154–160.
  • Yang, Y., et al., 2012. Effect of size, surface charge, and hydrophobicity of poly (amidoamine) dendrimers on their skin penetration. Biomacromolecules, 13(7), 2154–2162.
  • Yatvin, M.B., Stowell, M.H.B. 2002. Covalent polar lipid-conjugates with biologically active compounds for use in salves. United States Patent US6, 387, 876.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.